SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001132413-10-000010
Filing Date
2010-04-14
Accepted
2010-04-14 17:25:52
Documents
1
Group Members
ICS OPPORTUNITIES, LTD.INTEGRATED CORE STRATEGIES (US) LLCISRAEL A. ENGLANDERMILLENNIUM INTERNATIONAL MANAGEMNT GP LLCMILLENNIUM INTERNATIONAL MANAGEMNT LPMILLENNIUM MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 jav_sc13d-a1.htm SC 13D/A 557540
  Complete submission text file 0001132413-10-000010.txt   560135
Mailing Address 125 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 125 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617-349-4500
JAVELIN PHARMACEUTICALS, INC (Subject) CIK: 0000050710 (see all company filings)

IRS No.: 880471759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-62367 | Film No.: 10750147
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103
Business Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103 (212) 841-4100
MILLENCO LLC (Filed by) CIK: 0001132413 (see all company filings)

IRS No.: 133532932 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A